Charitable Donation Program
Earlier wound care, brought to the communities that go without it.
Meridian Wound Care LLC acquires antimicrobial wound-care product and donates it to qualifying public charities — at no cost to the charity or the people they serve.
This site is not an offer to sell or a solicitation to buy any security. Any offer is made only through the confidential Private Placement Memorandum to verified accredited investors.
Public-health figures drawn from the Company materials; illustrative of the access gap the program is designed to address.
The need
The problem isn't only that wounds are costly. It's that care often arrives too late.
Wound-care intervention frequently begins only after infection, hospitalization, and amputation risk have already escalated — when care is most expensive and outcomes are worst. The gap is concentrated where early products have historically been least available.
Reactive, not preventive
When a wound is treated only after it deteriorates, care becomes reactive — driving hospitalization, amputation risk, and large downstream cost.
Access concentrated by geography & setting
Elderly, long-term-care, rural, tribal, and medically underserved communities often face practical barriers to early wound-care products.
Much of the cost is preventable
A large share of the burden arises only after the point where earlier intervention might have changed the trajectory.
Meridian Wound Care is a charitable access program built for exactly these settings. It is designed to expand access to antimicrobial wound-care products — not to generate any economic return.
How the program works
A simple charitable pathway, with each role clearly defined.
The Company acquires the product and donates it. Qualified public charities receive and deploy it. Clinical decisions stay with qualified medical professionals.
Acquire & donate
Meridian Wound Care LLC acquires SilvrSTAT® product, confirms each charity's eligibility, and donates the product — transferring full legal and beneficial ownership — while maintaining acquisition, valuation, and substantiation records.
Receive & deploy
Each qualifying §501(c)(3) public charity takes title and deploys the product to eligible recipients through its own charitable programs and clinical channels, in furtherance of its exempt healthcare purpose.
Direct clinical use
Qualified medical professionals direct how the product is used. The Company provides no medical services, makes no clinical determinations, and guarantees no patient outcome.
Charitable benefit flows to recipients (no-cost access through charity channels), to Donees (a donated program asset, subject to related-use fit and operational capacity), and to participating Members (a potential distributive share of the Company's charitable contribution deduction, reported on Schedule K-1). No deduction amount or tax result is guaranteed.
The product
SilvrSTAT® antibacterial wound dressing gel
A silver-based antimicrobial wound dressing gel that clinicians have used for more than twenty years. The program concerns only the 4.1-ounce tubes the Company acquires for charitable donation.
- FDA cleared as a 510(k) medical device, indicated for the management of minor cuts, lacerations, abrasions, first- and second-degree burns, and skin irritations.
- Laboratory-tested antimicrobial activity against organisms including S. aureus, P. aeruginosa, E. coli, MRSA, and VRE.
- Simple topical use — no special equipment, processing, or laboratory work.
- Not represented to cure wounds or guarantee outcomes; clinical decisions belong to qualified professionals.
4.1-oz tube
Acquired for charitable donation only
SilvrSTAT® and its intellectual property are owned and retained by the manufacturer or its licensors. The Company does not manufacture the product and provides no medical services.
Who can participate
Participation is offered only to verified accredited investors.
Participants subscribe for Class A membership units in the Company. The program is structured as a charitable donation program — it is not designed to produce income, yield, capital appreciation, or any investment return. Any charitable contribution deduction under §170 runs, if at all, to the Company and its Members; it is contingent and is never guaranteed.
How it is offered
- Offered solely under Rule 506(c) of Regulation D.
- Open only to accredited investors, whose status is verified — not self-certified.
- Offered exclusively through the confidential Private Placement Memorandum.
- Class A membership units — not a publicly traded or transferable security.
What a participant should expect
- A charitable program, not an income- or growth-oriented investment.
- A potential, contingent charitable deduction — subject to IRS review and not guaranteed.
- Substantiation through a qualified appraisal, Form 8283, and Donee acknowledgment.
- Review of the full PPM and consultation with independent advisors before deciding.
Class A units have not been registered under the Securities Act of 1933 or any state securities laws and are offered in reliance on exemptions from registration, including Rule 506(c). Participation involves significant risk, including loss of the entire capital contribution and the risk that anticipated charitable contribution deductions may be challenged, reduced, deferred, limited, recharacterized, or disallowed. No deduction amount or tax result is guaranteed.
For §501(c)(3) public charities
Extend wound care to the communities you already serve — at no cost.
If your organization provides wound care or related health services to underserved communities, you may qualify to receive donated SilvrSTAT® product. There is never a charge to your organization or to the people you help.
Meridian handles shipping coordination, IRS-compliant donation paperwork prepared for you, and program guidance. Your organization confirms eligibility, takes title to the product, distributes it through your programs in accordance with the product labeling, and shares periodic aggregate, de-identified impact reporting.
- §501(c)(3) recognized and tax-exempt under §501(a)
- Public charity under §509(a)(1) or §509(a)(2) — not a private foundation, supporting organization, or donor-advised fund
- Currently listed & deductible in IRS Pub 78 / TEOS, and not on the Auto-Revocation List
- Active good standing and state charity registration where required
- Clears OFAC / sanctions screening
- Related use — your programs provide wound care or related health services to the population you serve
- Serves medically underserved, rural, or higher-risk communities
Common questions
What people ask first
Is this an investment?
No. This is a charitable donation program. The program is structured to have no income, yield, capital appreciation, or economic return. Participants subscribe for Class A membership units; the Company owns the product and donates it to qualifying public charities.
Does a participant buy or own the product?
No. A prospective subscriber subscribes for Class A units. The Company acquires and owns the product and makes the charitable donation. Any Member-level tax benefit is expected to arise from the Company's charitable contribution and partnership reporting — not from a direct donation by the subscriber. No deduction amount or tax result is guaranteed.
Is the charitable deduction guaranteed?
No. Any charitable contribution deduction under §170 is contingent. It depends on a qualified appraisal and proper substantiation, is subject to review by the IRS and state taxing authorities, and may be challenged, reduced, deferred, limited, recharacterized, or disallowed. The deduction, if available at all, runs to the Company and its Members — never to the donee charities. Consult your own tax advisor.
Who can participate?
Participation is offered only to accredited investors whose status is verified, under Rule 506(c) of Regulation D. Any offer is made solely through the confidential Private Placement Memorandum. This website is general information only and is not an offer to sell or a solicitation to buy any security.
What does a charity receive?
Qualifying §501(c)(3) public charities receive donated product only — no payment, securities, or economic return, and no tax deduction. Charities take title to the product and deploy it to eligible recipients through their own charitable programs and clinical channels.
Does Meridian provide medical care?
No. The Company does not provide medical services, make clinical determinations, deliver patient care, or guarantee outcomes. Qualified medical professionals direct how the product is used. SilvrSTAT® is an antibacterial wound dressing gel, FDA cleared as a 510(k) medical device, and is not represented to cure wounds.
Get started
Request information about the program.
Tell us a little about you and we'll follow up. Prospective subscribers are routed into the Company's accredited-investor verification process; offering documents are provided only after verification.
Submitting a request does not create any commitment and does not constitute a subscription. No offer to sell, and no solicitation to buy, any security is made through this website. Any offer is made solely through the Private Placement Memorandum to verified accredited investors.
Questions? A Meridian person is here to help.
William Tanenbaum — Manager, Meridian Wound Care MGMT LLC
Program & charitable partnerships: wtanenbaum@meridianwound.care
Full detail — vetting checklist, partnership packet, and policy & procedure manual — available on request to qualifying charities.
Meridian Wound Care LLC
c/o Meridian Wound Care MGMT LLC
9561 South 700 East, #202
Sandy, Utah 84070